Skip to main content
. Author manuscript; available in PMC: 2018 Jun 6.
Published in final edited form as: Clin Sci (Lond). 2018 Jan 25;132(2):295–312. doi: 10.1042/CS20171416

Figure 7. Validation of three unique pathways altered by maternal VSG in the placenta.

Figure 7

(A) Analysis of MMP9 protein by Western blot and normalized to β actin. (B) Protein levels of mTOR normalized to β actin by western blot. N = 3-5/group. (C) TUNEL staining of Lean, VSG and Obese placenta with positive control (PC) shown N=9-13/group. One way ANOVA with Tukey’s post hoc, *P < 0.05, **P < 0.01, ***P < 0.001. Data are presented as mean ±SEM.